Evaluation of Liquid vs. Tablet Buprenorphine - 6

NCT00000341 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

1

Enrollment

NIH

Sponsor class

Conditions

Opioid-Related Disorders

Interventions

DRUG: Buprenorphine

Sponsor

National Institute on Drug Abuse (NIDA)